Hippocratic AI, a pioneering healthcare AI company, has secured $126 million in Series C funding, elevating its valuation to $3.5 billion. The investment, led by Avenir Growth and supported by major players like CapitalG, Andreessen Horowitz, and healthcare systems like Universal Health Services, aims to enhance customer deployments globally and accelerate product innovation. Founded in 2024, Hippocratic AI is developing the first large language model tailored for healthcare, focusing on non-diagnostic, patient-facing tasks such as intake and medication adherence. Since launching its generative AI-powered healthcare agent in June 2022, the company has partnered with over 50 health organizations, achieving more than 115 million safe patient interactions. CEO Munjal Shah emphasizes that this capital will help expand their impact while adhering to their core values of safety and patient-centric care. Stay updated on the latest developments in digital health news.
Source link
